Tianlong Lan

664 total citations
8 papers, 405 citations indexed

About

Tianlong Lan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Tianlong Lan has authored 8 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Tianlong Lan's work include Protein Degradation and Inhibitors (3 papers), Catalytic C–H Functionalization Methods (2 papers) and CRISPR and Genetic Engineering (2 papers). Tianlong Lan is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Catalytic C–H Functionalization Methods (2 papers) and CRISPR and Genetic Engineering (2 papers). Tianlong Lan collaborates with scholars based in China, Australia and South Korea. Tianlong Lan's co-authors include Yu Rao, Qiuye Zhao, Shang Su, Liguo Wang, Wen Zheng, Xinyi Zhang, Xiuqin Zhang, Rui‐Ping Xiao, Jiannian Yao and Jianguo Zhao and has published in prestigious journals such as Oncogene, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Tianlong Lan

8 papers receiving 399 citations

Peers

Tianlong Lan

MB

ONCOL

OC

HEMAT

EEE

Mallesh Pandrala United States

Rupesh Nanjunda United States

Diego García Jiménez Italy

Nunzio Sciammetta United States

Reshmi Mukherjee India

Jianxin Gu United States

Raghu Vannam United States

Adaickapillai Mahendran United States

Mohamed A. Badawy Egypt

Viola Previtali Denmark

Mallesh Pandrala United States

Tianlong Lan

116 ×0.5

MB

104 ×0.8

ONCOL

103 ×0.9

OC

18 ×0.3

HEMAT

11 ×0.3

EEE

Citations per year, relative to Tianlong Lan Tianlong Lan (= 1×) peers Mallesh Pandrala

Countries citing papers authored by Tianlong Lan

Since Specialization

Citations

This map shows the geographic impact of Tianlong Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianlong Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianlong Lan more than expected).

Fields of papers citing papers by Tianlong Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianlong Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianlong Lan. The network helps show where Tianlong Lan may publish in the future.

Co-authorship network of co-authors of Tianlong Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Tianlong Lan. A scholar is included among the top collaborators of Tianlong Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianlong Lan. Tianlong Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Kong, Yanjie, Tianlong Lan, Gong Chen, et al.. (2024). BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression. Oncogene. 43(39). 2914–2926. 8 indexed citations

2.

Zhang, Qing, Wei Chen, Guangliang Chen, et al.. (2021). Trimetallic Octahedral Ni–Co–W Phosphoxide Sprouted from Plasma-Defect-Engineered Ni–Co Support for Ultrahigh-Performance Electrocatalytic Hydrogen Evolution. ACS Sustainable Chemistry & Engineering. 9(22). 7454–7465. 25 indexed citations

3.

Wang, Liguo, Yue Wu, Zhenzhen Li, et al.. (2021). Design and synthesis of water-soluble grifolin prodrugs for DNA methyltransferase 1 (DNMT1) down-regulation. RSC Advances. 11(61). 38907–38914. 1 indexed citations

4.

Sun, Xiuyun, Jun Wang, Xia Yao, et al.. (2019). A chemical approach for global protein knockdown from mice to non-human primates. Cell Discovery. 5(1). 10–10. 86 indexed citations

5.

Yang, Yiqing, Lin Cao, Hongying Gao, et al.. (2019). Discovery, Optimization, and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors. Journal of Medicinal Chemistry. 62(8). 4056–4073. 46 indexed citations

6.

Zhao, Qiuye, Tianlong Lan, Shang Su, & Yu Rao. (2018). Induction of apoptosis in MDA-MB-231 breast cancer cells by a PARP1-targeting PROTAC small molecule. Chemical Communications. 55(3). 369–372. 138 indexed citations

7.

Lan, Tianlong, Liguo Wang, & Yu Rao. (2017). Regioselective Annulation of Aryl Sulfonamides with Allenes through Cobalt-Promoted C–H Functionalization. Organic Letters. 19(5). 972–975. 66 indexed citations

8.

Hu, Jiantao, Tianlong Lan, Yihua Sun, et al.. (2015). Unactivated C(sp³)–H hydroxylation through palladium catalysis with H₂O as the oxygen source. Chemical Communications. 51(80). 14929–14932. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact